Received Jun 2, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMR | MEASLES + MUMPS + RUBELLA (PRIORIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | 7hg2a | — |
possible improper reconstitution/eceived Priorix reconstituted with Merck's MMR vaccine diluent; possible improper reconstitution/eceived Priorix reconstituted with Merck's MMR vaccine diluent; This non-serious case was reported by a nurse via call center representative and described the occurrence of wrong solution used in drug reconstitution in a patient who received MMR (Priorix) (batch number 7hg2a, expiry date 01-JAN-2026) for prophylaxis. On 29-MAY-2025, the patient received Priorix. On 29-MAY-2025, an unknown time after receiving Priorix, the patient experienced wrong solution used in drug reconstitution (Verbatim: possible improper reconstitution/eceived Priorix reconstituted with Merck's MMR vaccine diluent) and inappropriate dose of vaccine administered (Verbatim: possible improper reconstitution/eceived Priorix reconstituted with Merck's MMR vaccine diluent). The outcome of the wrong solution used in drug reconstitution and inappropriate dose of vaccine administered were not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK receipt date: 30-MAY-2025 Nurse practitioner reported that there was a possibility that a patient might have received Priorix reconstituted with Merck's MMR vaccine diluent one day prior to the reporting date, which led to wrong solution used in drug reconstitution and inappropriate dose of vaccine administered. She was still gathering information. No patient details or other information available at this time.